MNKD FY 2022 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$100M+32.2% YoY

Gross Profit

$42M42.4% margin

Operating Income

-$64M-64.3% margin

Net Income

-$87M-87.6% margin

EPS (Diluted)

$-0.44

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$88M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$295M

Total Liabilities

$546M

Stockholders' Equity

-$251M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$100M	$75M	+32.2%
Gross Profit	$42M	$37M	+15.5%
Operating Income	-$64M	-$47M	-36.3%
Net Income	-$87M	-$81M	-8.0%